What Is Amarin Corporation plc (AMRN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Amarin Corporation plc's intrinsic value is estimated at $18.25, suggesting a +24.2% average upside from the current price of $14.70. While 8 models see room for appreciation, model agreement is not unanimous as 4 models flag potential overvaluation. Model dispersion is worth noting: FTNN targets $33.57 (+128.4%), versus ML-RIV at $3.01 (-79.5%). This +207.9% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About AMRN?
13 of 13 models are currently active for AMRN. Of these, 8 models suggest upside while 5 models suggest overvaluation. The Bayesian DCF estimates AMRN's intrinsic value at $7.34, implying -50.0% downside from the current price. See which stocks rank higher →
How Does AMRN Rank in Drug Manufacturers - General?
Among 3 Drug Manufacturers - General stocks, AMRN ranks #3 by Quality of Company score. CirclFi's QOC score of 6.0/10 evaluates 32 fundamental signals. A score of 6.0 reflects mixed fundamentals.
Amarin Corporation plc's positioning within the Drug Manufacturers - General segment means that clinical trial success rate plays an outsized role in fundamental analysis. The sector's unique characteristics — including licensing and M&A optionality — shape both the opportunity set and risk profile.
Is AMRN a Value Trap?
CirclFi's Value Trap algorithm assigns AMRN a score of 40/100 (WARN). This is a warning signal. Additional research into recent 10-Q filings is recommended. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Amarin Corporation plc. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Amarin Corporation plc earns a quality score of 6.0/10. This respectable rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +207.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every AMRN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across AMRN's 13 active models, average confidence is 24%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad